MedPath

Talima Therapeutics, Inc.

Talima Therapeutics, Inc. logo
🇺🇸United States
Ownership
Private
Established
2004-01-01
Employees
1
Market Cap
-
Website
http://www.talima.com

A Study to Evaluate TMI-358 in the Treatment of Distal Subungual Onychomycosis

Phase 2
Terminated
Conditions
Distal Subungual Onychomycosis
Interventions
Drug: MMI-467
First Posted Date
2010-03-25
Last Posted Date
2011-01-17
Lead Sponsor
Talima Therapeutics, Inc.
Target Recruit Count
120
Registration Number
NCT01093118
Locations
🇺🇸

Therapeutics Clinical Research, San Diego, California, United States

🇺🇸

International Dermatology Research Center, Miami, Florida, United States

🇺🇸

J&S Studies, Inc., College Station, Texas, United States

and more 3 locations
© Copyright 2025. All Rights Reserved by MedPath